FIBA Anti-Doping activities target compliance with Book 4 of FIBA Internal regulations. The above table lists only sanctions imposed and currently in force in cases where FIBA acted as a Results Management Authority. FIBA does not list sanctions imposed by other anti-doping organizations.
Player | Nationality | Substance | Decision | Expiration of suspension | Anti-Doping Rule Violation Committed |
Markis McDUFFIE | USA | MDMA (Methylenedioxymethamphetamine) and Tenamfetamine (Methylenedioxyamfetamine) | 3 months suspension | 29 September 2025 | Use of a Prohibited Substance - Articles 2.1 and 2.2 FIBA ADR |
Daniel BEJERANO | Mexico/USA |
| 9 months suspension | 9 January 2026 | Use of a Prohibited Substance - Articles 2.1 and 2.2 FIBA ADR |
Sami BZAI | Jordan | dehydrochloromethyl-testosterone metabolite | 3 years suspension | 27 October 2026 | Use of a Prohibited Substance - Articles 2.1 and 2.2 FIBA ADR |
Pierria Lee-Vaughntay HENRY | Senegal/USA | Prohibited Method | 48 months suspension | 13 January 2027 | Use of a Prohibited Method - Article 2.2 FIBA ADR |
HAAZ MANTEROLA Gabriela | Mexico | Deflazacort | 4 years of suspension | 8 January 2029 | Administration of a Prohibited Substance Article 2.8 and 2.9 FIBA ADR |
Narlyn Tathiana MOSQUERA | Colombia |
| 6 years suspension | 17 June 2030 | Violations of period of ineligibility - Article 10.14 FIBA ADR |